Assays for determination of ertapenem for applications in therapeutic drug monitoring, pharmacokinetics and sample stability

Biomedical Chromatography

Volumn 28, Issue 11, 2014, Pages 1525-1531

  Pickering, Matthew K ^a   Brown, Stacy D ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Applications; Carbepenems; Ertapenem; HPLC; Protein precipitation

Indexed keywords

ANTIBIOTICS; BIOCHEMISTRY; DRUG DOSAGE; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PROTEINS; TEMPERATURE;

BIOLOGICAL MATRIXES; BROAD SPECTRUM; CARBEPENEMS; ERTAPENEM; HPLC; PLASMA PROTEIN BINDING; PROTEIN PRECIPITATION; THERAPEUTIC DRUG MONITORING; Β-LACTAM ANTIBIOTICS; Β-LACTAMASE;

PHASE SEPARATION;

ERTAPENEM; BETA LACTAM;

ANALYTIC METHOD; DRUG DETERMINATION; DRUG MONITORING; DRUG STABILITY; HUMAN; REVIEW; BLOOD; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PROCEDURES;

BETA-LACTAMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS;

EID: 84911959536     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.3301     Document Type: Review

References (45)

1. Abraham EP and Chain E. An enzyme from bacteria able to destroy penicillin. Reviews of Infectious Disease 1940; 10: 677-678.
2. Aminov RI. A brief history of the antibiotic era: lessons learned and challenges for the future. Frontiers in Microbiology 2010; 1: 134.
3. Arrigucci S, Garcea A, Fallani S, Cassetta MI, Canonico G, Tonelli F, Mazei T and Novelli A. Ertapenem peritoneal fluid concentrations in adult surgical patients. International Journal of Antimicrobial Agents 2009; 33: 371-373.
4. Bauer LA. Drug dosing in special populations: renal and hepatic disease, dialysis, heart failure, obesity, and drug interactions. In: Applied Clinical Pharmacokinetics, 2nd edn, Bauer LA (ed.). McGraw-Hill: New York, 2008.
5. Brink AJ, Richards GA, Schillack V, Kiem S and Schentag J. Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis. International Journal of Antimicrobial Agents 2009; 33: 432-436.
6. Briscoe SE, McWhinney BC, Lipman J, Roberts JA and Ungerer JPJ. A method for determining the free (unbound) concentration of ten beta-lactam antibiotics in human plasma using high performance liquid chromatography with ultraviolet detection. Journal of Chromatography B 2012; 907: 178-184.
7. Chen M, Nafziger AN, Drusano GL, Ma L and Bertino Jr JS. Comparative pharmacokinetics and pharmacodynamic target attainment of ertapenem in normal-weight, obese, and extremely obese adults. Antimicrobial Agents and Chemotherapy 2006; 50(4): 1222-1227.
8. Cielecka-Piontek J. Zajac M and Jelinska A. A comparison of the stability of ertapenem and meropenem in pharmaceutical preparations in solid state. Journal of Pharmaceutical and Biomedical Analysis 2008; 46: 52-57.
9. Dailly, E, Bouquie R, Deslandes G, Jolliet P and LeFloch R. A liquid chromatography assay for a quantification of doripenem, ertapenem, imipenem, and meropenem concentrations in human plasma: application to a clinical pharmacokinetic study. Journal of Chromatography B 2011; 879: 1137-1142.
10. Davies J and Davies D. Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews 2010; 74(3): 417-433.
11. De Castro WV, Marchand S, Lamarche I and Cout W. Effect of experimentally induced hypovolemia on ertapenem tissue distribution using microdialysis in rats. European Journal of Pharmaceutical Science 2014; 51: 45-50.
12. Demiralay EC, Koc D, Daldal YD and Cakir C. Determination of chromatographic and spectrophotometric dissociation constants of some beta-lactam antibiotics. Journal of Pharmaceutical and Biomedical Analysis 2012; 71: 139-143.
13. Gordien KB, Boselli E, Fleureau C, Allaouchiche B, Janvier G, Lalaude O, Saux MC and Breilh D. Determination of free ertapenem in plasma and bronchoalveolar lavage by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography B 2006; 830: 218-223.
14. Hashizume T, Ishino F, Nakagawa J, Tamaki S and Matsuhashi M. Studies on the mechanism of action of imipenem (N-formimidoylthienamycin) in vitro: binding to the penicillin-binding proteins (PBPs) in Escherichia coli and Pseudomonas aeruginosa, and inhibition of enzyme activities due to the PBPs in E. coli. Journal of Antibiotics (Tokyo) 1984; 37: 394-400.
15. Hayashi Y, Lipman J, Udy AA, Ng M, McWhinney B, Ungerer J, Lust K and Roberts JA. Beta-lactam therapeutic drug monitoring in the critically ill: optimizing drug exposure in patients with fluctuating renal function and hypoalbuminaemia. International Journal of Antimicrobial Agents 2013; 41: 162-166.
16. Hites M, Taccone FS, Wolff F et al. Case-control study of drug monitoring of beta-lactams in obese critically ill patients. Antimicrobial Agents and Chemotherapy 2013; 57: 708-715.
17. Invanz. Package insert. Merck & Co. Inc.: Whitehouse Station, NJ, 2011.
18. Kahan JS, Kahan FM, Goegelman R, Currie SA, Jackson M, Stapley EO, Miller TW, Miller AK, Hendlin D, Mochales S, Hernandez S, Woodruff HB and Birnbaum J. Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties. Journal of Antibiotics (Tokyo) 1979; 32(1): 1-12.
19. Kitchen CJ, Musson DG and AL Fisher. Column-switching technique for the sensitive determination of ertapenem in human cerebrospinal fluid using liquid chromatography and ultraviolet absorbance detection. Journal of Chromatography B 2004; 799: 9-14.
20. Koal T, Deters M, Resch K and Kaever V. Quantification of the carbapenem antibiotics ertapenem in human plasma by a validated liquid chromatography-mass spectrometry method. Clinica Chemica Acta 2006; 364: 239-245.
21. La Marca G, Giocaliere E, Villanelli F, Malvagia S, Funghini S, Ombrone D, Filippi L, De Gaudio M, De Martino M and Galli L. Development of an UPLC-MS/MS method for the determination of antibiotic ertapenem on dried blood spots. Journal of Pharmaceutical and Biomedical Analysis 2012; 61: 108-113.
22. Lefeurve S, Venisse N, Marchand S, Bachelet M and Cout M. A simple and sensitive liquid -chromatography-tandem mass spectrometry assay for the quantification of ertapenem in microdialysate. Journal of Chromatography B 2008; 862: 242-245.
23. Legrand T, Chhun S, Rey E, Blanchet B, Zahar JR, Lanternier F, Pons G and Jullien V. Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection. Journal of Chromatography B 2008; 875: 551-556.
24. Livermore DM, Mushtaq S and Warner M. Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems. Journal of Antimicrobial Chemotherapy 2005; 55: 306-311.
25. McWhinney BC, Wallis SC, Hillister T, Roberts JA, Lipman J and Ungerer JPJ. Analysis of 12 beta-lactam antibiotics in human plasma by HPLC and ultraviolet detection. Journal of Chromatography B 2010; 878: 2030-2043.
26. Michalska K, Pajchel G and Tyski S. Different sample stacking strategies for the determination of ertapenem and its impurities by micellar electrokinetic chromatography in pharmaceutical formulation. Journal of Chromatography A 2009; 1216: 2934-2942.
27. Michalska K, Cielecka-Piontek J, Pajchel G and Tyski S. Determination of biapenem in a medicinal product by micellar electrokeintic chromatography with sweeping in an enhanced electric field. Journal of Chromatography A 2013; 1282: 153-160.
28. Mistry GC, Majumdar AK, Swan S, Sica D, Fisher A, Xu Y, Hesney M, Xi L, Wagner JA and Deutsch PJ. Pharmacokinetics of ertapenem in patients with varying degrees of renal insufficiency and in patients on hemodialysis. Journal of Clinical Pharmacology 2006; 46: 1128-1138.
29. Mouton JW, Touzw DJ, Horrevorts AM and Vinks AA. Comparative pharmacokinetics of the carbapenems: clinical implications. Clinical Pharmacokinetics 2000; 39(3): 185-201.
30. Mundkowski RG, Majcher-Peszynska J, Burkhardt O, Welte T and Drewelow B. A new simple HPLC assay for the quantification of ertapenem in human plasma, lung tissue, and broncho-alveolar lavage fluid. Journal of Chromatography B 2006; 832: 231-235.
31. Musson DG, Birk KL, Cairns AM, Majumdar AK and Rogers JD. High-performance liquid chromatographic methods for the determination of a new carbapanem antibiotic L-749, 346, in human plasma and urine. Journal of Chromatography B 1998; 720: 99-106.
32. Musson DG, Kitchen CJ, Hsieh JYK and Birk KL. Modified high-performance liquid choromatographic method for the determination of ertapenem in human urine: enhanced selectivity and automation. Journal of Chromatography B 2002; 779: 341-346.
33. Musson DG, Birk KL, Kitchen CJ, Zhang J, Hsieh JYK, Fang W, Majumdar AK and Rogers JD. Assay methodology for the quantification of unbound ertapenem, a new carbapenem antibiotic in human plasma. Journal of Chromatography B 2003; 783: 1-9.
34. Nix DE, Majumdar AK and DiNubile MJ. Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians. Journal of Antimicrobial Chemotherapy 2004; 53(suppl. S2): ii23-ii28.
35. Papp-Wallace KM, Endimiani A, Taracila MA and Bonomo RA. Carbapenems: past, present, and future. Antimicrobial Agents and Chemotherapy 2011; 55(11): 4943-4960.
36. Peaper DR, Kulkarni MV, Tichy AN, Jarvis M, Murray TS and Hodsdon ME. Rapid detection of carbapenemase activity through monitoring ertapenem hydrolysis in Enterobacteriaceae with LC-MS/MS. Bioanalysis 2013; 5(2): 147-157.
37. Pickering M and Brown S. Quantification and validation of HPLC-UV and LC-MS assays for therapeutic drug monitoring or ertapenem in human plasma. Biomedical Chromatography 2013; 27(5): 568-574.
38. Roberts JA, Ulldemolins M, Roberts MS, McWhinney B, Ungerer J, Paterson DL and Lipman J. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept. International Journal of Antimicrobial Agents 2010; 36: 332-329.
39. Sajonz P, Vailaya A, Sudah O, McPherson L, Capodanno V, Natishan TK, Helmy R and Anita FD. Development of a gradient elution preparative high-performance liquid chromatography method for the recovery of the antibiotic ertapenem from crystallization process streams. Journal of Chromatography A 2006; 1126: 365-372.
40. Shah PM and Isaacs RD. Ertapenem, the first of the new group of carbapenems. Journal of Antimicrobial Chemotherapy 2003; 52: 538-542.
41. Soltani M, MacGowan AP and Lovering AM. Assay of ertapenem in human serum by high-performance liquid chromatography. International Journal of Antimicrobial Agents 2006; 27: 165-167.
42. Sutherland C and Nicolau DP. Development of an HPLC method for the determination of doripenem in human and mouse serum. Journal of Chromatography B 2007; 853: 123-126.
43. Vailaya A, Sanjonz P, Sudah O, Capodanno V, Helmy R and Anita FD. Exploiting pH mismatch in preparative high-performance liquid chromatographic recovery of ertapenem from mother liquor streams. Journal of Chromatography A 2005; 1079: 80-91.
44. Yost RL and Derendorf H. Disposition of cefotaxime and its desacetyl metabolite in morbidly obese male and female subjects. Therapeutic Drug Monitoring 1986; 8: 189-194.
45. Zajac M, Cielecka-Piontek J and Jelinska A. Stability of ertapenem in aqueous solutions. Journal of Pharmaceutical and Biomedical Analysis 2007; 43: 445-449.